We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MU:NASDAQMicron Technology, Inc. Analysis

Data as of 2026-09-06 - not real-time

$1,016.59

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Micron Technology, Inc. is bullish at $1,016.59, with short-term averages leading the long-term ones. It has gained 10.4% over the past 30 days. RSI sits at 60.1, which reads as approaching overbought, and MACD momentum is bullish. Recent trading has carved out support near $844.62 and resistance around $1,036.13.
The shares look undervalued, trading on 23.0 times earnings below a sector average of 33.2. Sell-side targets cluster 48.8% above the current quote. Revenue is growing at 345.7% on a 55.9% profit margin. The 0.05% dividend yield looks covered by current payout levels.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 83.8%, a beta of 3.36 and a maximum drawdown of 39.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.

Top Market Events

BOISE, Idaho, Aug. 26, 2026 GLOBE NEWSWIRE -- Micron Technology, Inc. Nasdaq: MU announced today that it will hold its...Micron MU stock climbed 2% premarket as DRAM prices forecast 50% rise this quarter.Ad Hoc News12dMicron Technology stock slips after sharp rally as AI earnings outlook stays strongMicron Technology...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 606.48
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 23.0 versus sector average of 33.2
  • Trading above the 200-day average of 606.48

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 23.0 versus sector average of 33.2
  • Analyst targets imply +48.8% versus the current price
  • Profit margin of 55.9% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth345.70%
Profit Margin55.91%
P/E Ratio23.0
ROE66.64%
ROA34.87%
Debt/Equity6.33
P/B Ratio11.4
Op. Cash Flow$51.4B
Free Cash Flow$7.6B
Industry P/E33.2

Technical Analysis

TrendBullish
RSI60.1
Support$844.62
Resistance$1,036.13
MA 20$943.30
MA 50$938.28
MA 200$606.48
MACDBullish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair Value$250.80
Target Price$1,513.11
Upside/Downside48.84%
GradeUndervalued
TypeGrowth
Dividend Yield0.05%

Risk Assessment

Beta3.36
Volatility83.79%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.